Beta-Cell Function and Glycemic Control Following One-Year Vildagliptin Treatment, and after 12-Week Washout, in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia

被引：0
|
作者：
Bunck, Mathijs C.
Poelma, Marieke
Goede, Diane L.
Van Golen, Larissa W.
Van Genugten, Renate E.
Eekhoff, E. Marelise
Schweizer, Anja
Heine, Robert J.
Foley, James E.
Nijpels, Giel
Diamant, Michaela
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A17 / A17
页数：1
相关论文
共 40 条
  • [1] Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
    Foley, J. E.
    Bunck, M. C.
    Moller-Goede, D. L.
    Poelma, M.
    Nijpels, G.
    Eekhoff, E. M.
    Schweizer, A.
    Heine, R. J.
    Diamant, M.
    DIABETOLOGIA, 2011, 54 (08) : 1985 - 1991
  • [2] Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
    J. E. Foley
    M. C. Bunck
    D. L. Möller-Goede
    M. Poelma
    G. Nijpels
    E. M. Eekhoff
    A. Schweizer
    R. J. Heine
    M. Diamant
    Diabetologia, 2011, 54 : 1985 - 1991
  • [3] One-Year Vildagliptin, Compared to Placebo, Treatment Does Not Affect Markers of Bone Resorption and Calcium Homeostasis in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia
    Diamant, Michaela
    Poelma, Marieke
    Goede, Diane L.
    Van Golen, Larissa W.
    Van Genugten, Renate E.
    Eekhoff, E. Marelise
    Schweizer, Anja
    Heine, Robert J.
    Foley, James E.
    Nijpels, Giel
    Bunck, Mathijs C.
    DIABETES, 2010, 59 : A192 - A193
  • [4] Sustained efficacy and tolerability of vildagliptin monotherapy during one-year treatment of drug-naive patients with type 2 diabetes
    Goekel, B.
    Schweizer, A.
    Couturier, A.
    LeBeaut, A.
    Dejager, S.
    DIABETOLOGIA, 2006, 49 : 28 - 28
  • [5] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    DIABETES, 2007, 56 : A134 - A134
  • [6] β-cell function and glycemic control following one year exenatide therapy, and after 12 week wash out, in patients with type 2 diabetes
    Bunck, Mathijs C.
    Diamant, Michaela
    Corner, Anja
    Eliasson, Bjorn
    Malloy, Jaret L.
    Shaginian, Rimma M.
    Ding, Wei
    Kendall, David M.
    Taskinen, Marja-Ritta
    Smith, Ulf
    Yki-Jarvinen, Hannele
    Heine, Robert J.
    DIABETES, 2008, 57 : A32 - A32
  • [7] Beta cell function and glycaemic control following one year exenatide therapy, and after 12 week wash-out, in patients with type 2 diabetes
    Corner, A.
    Bunck, M. C.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M. R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    DIABETOLOGIA, 2008, 51 : S351 - S351
  • [8] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
  • [9] Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naive Patients with Type 2 Diabetes Mellitus
    Kong, Sung Hye
    Koo, Bo Kyung
    Moon, Min Kyong
    DIABETES & METABOLISM JOURNAL, 2019, 43 (05) : 711 - 717
  • [10] Sitagliptin added to ongoing metformin therapy enhanced glycemic control and beta-cell function in patients with type 2 diabetes
    Karasik, Avraham
    Charbonnel, Bernard
    Liu, Ji
    Wu, Mei
    Meehan, Alan
    Meininger, Gary
    DIABETES, 2006, 55 : A119 - A120
1234